Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-767-7 | CAS number: 2893-78-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study not performed to GLP or guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- GLP compliance:
- no
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Sodium cyanurate
- IUPAC Name:
- Sodium cyanurate
- Details on test material:
- - Name of test material (as cited in study report): Sodium cyanurate
- Analytical purity: 99.6%
- Lot/batch No.: 1219642-2
- Storage condition of test material: Room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Simonsen Laboratories, Gilroy, CA
- Weight at study initiation: 160 - 210g
- Diet: ad libitum
- Water: ad libitum
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: 4% carboxymethyl cellulose
- Lot/batch no: Sigma chemical company, Lot 77C-0334 - Duration of treatment / exposure:
- 24 h and 48 h after treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1.25, 2.50 and 5.00 g/kg bw
Basis:
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- triethylenemelamine
- Route of administration: Intraperitoneal
- Doses / concentrations:0.275 mg/kg
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
-
TREATMENT AND SAMPLING TIMES : 24 and 48 h after treatment
DETAILS OF SLIDE PREPARATION: Clean labeled slides were dipped in distilled water and the cell suspensions were dropped onto the slides using Pasteur pipettes. The slides were then passed over a flame from an alcohol lamp and allowed to dry inside a fume hood. Eight slides were made from each animal. Cells on the slides were stained in freshly prepared 7% Giemsa stain (Gurr R66 Giemsa, M/15 Sorensens buffer, pH 6.8) for 10 minutes at room temperature. The stained slides were rinsed in deionized water, air dried and dipped in xylene, and coverslips were mounted with Depex mounting medium.
METHOD OF ANALYSIS: 50 cells were analyzed from each animal in the study. 1000 cells per animal were examined to determine the mitotic index (MI).For each metaphase cell analyzed for chromosomal aberrations, the vernier setting, chromosome number, and the number and types of aberrations recorded. Aberrations were classified, as described by Savage (1975), as chromosome-type or chromatid-type and were further classified as deletionsor exchanges. Cells bearing aberrations were classified as 'severley damaged cells'.
- Evaluation criteria:
- numbers and types of structural aberrations , mitotic index
- Statistics:
- For each treatment group, data on aberrations per cell was checked for conformity to a Poisson distribution. If the data followed a Poisson distribution, the means for each group were subjected to a square root transformation. If the results did not conform to a Poisson ditribution, a square-root transformation was perfomed on the numbers of chromosomal aberrations per cell and means from each group were calculated from the transformed data. Using the transformed data, the Students t-test was performed to compare the frequency of chromosomal aberrations per cell in a treatment group with that of a negative control. Differences were considered statistically significant when p < 0.05.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
Any other information on results incl. tables
Table1: Cytogenetic evaluation of bone marrow cells from male rats exposed to sodium cyanurate by oral gavage: 24 hours
Negative control |
Low dose (1.25 g/kg) |
Mid dose (2.50 g/kg) |
High dose (5.0 g/kg) |
Positive control (0.275 mg/kg TEM) |
|
No of animals |
5 |
5 |
5 |
5 |
5 |
Mitotic index (%) |
5.28 ± 0.79 |
5.74 ± 0.71 |
7.28 ± 0.94 |
6.49 ± 0.96 |
4.39 ± 0.60 |
No of cells analyzed |
250 |
250 |
238 |
239 |
238 |
No (%) normal cells |
231 (92) |
231 (92) |
224 (94) |
227 (95) |
159 (67) |
Number (%) abnormal cells |
19 (8) |
19 (8) |
14 (6) |
12 (5) |
79 (33) |
Number of gaps per cell (mean ± SEM) |
0.05 ± 0.004 |
0.07 ± 0.008 |
0.04 ± 0.003 |
0.03 ± 0.003 |
0.10 ± 0.008 |
Number (%) abnormal cells with: |
|||||
Chromosome deletions |
1 (0.4) |
1 (0.4) |
1 (0.4) |
0 |
8 (3.4) |
Chromosome exchanges |
0 |
0 |
1 (0.4) |
1 (0.4) |
4 (1.7) |
Chromatid deletions |
7 (2.8) |
8 (3.2) |
7 (2.9) |
6 (2.5) |
50 (21.0) |
Chromatid exchanges |
8 (3.2) |
13 (5.2) |
2 (0.8) |
5 (2.1) |
32 (13.4) |
Aneuploidy |
4 (1.6) |
2 (0.8) |
4 (1.7) |
1 (0.4) |
5 (2.1) |
Polyploidy |
0 |
1 (0.4) |
1 (0.4) |
0 |
0 |
Severe damage |
0 |
0 |
0 |
0 |
3 (1.3) |
Types of aberrations per cell: |
|||||
Overall frequency of aberrations (mean ± SEM) |
0.08 ± 0.02 |
0.08 ± 0.02 |
0.07 ± 0.02 |
0.05 ± 0.02 |
0.89 ± 0.12* |
Chromosome deletions |
0.004 |
0.004 |
0.004 |
0.000 |
0.040 |
Chromosome exchanges |
0.000 |
0.000 |
0.004 |
0.004 |
0.020 |
Chromatid deletions |
0.03 |
0.03 |
0.03 |
0.03 |
0.50 |
Chromatid exchanges |
0.03 |
0.03 |
0.01 |
0.03 |
0.20 |
Table 2: Cytogenetic evaluation of bone marrow cells from male rats exposed to sodium cyanurate by oral gavage: 48 hours
Negative control |
Low dose (1.25 g/kg) |
Mid dose (2.50 g/kg) |
High dose (5.0 g/kg) |
Positive control (0.275 mg/kg TEM) |
|
No of animals |
5 |
5 |
5 |
5 |
5 |
Mitotic index (%) |
5.25 ± 0.21 |
5.31 ± 0.18 |
4.52 ± 0.18 |
4.37 ± 0.24 |
5.52 ± 0.24 |
No of cells analyzed |
239 |
250 |
250 |
226 |
250 |
No (%) normal cells |
224 (94) |
229 (92) |
224 (90) |
210 (93) |
110 (44) |
Number (%) abnormal cells |
15 (6) |
21 (8) |
26 (10) |
16 (7) |
140 (56) |
Number of gaps per cell (mean ± SEM) |
0.06 ± 0.008 |
0.05 ± 0.005 |
0.07 ± 0.005 |
0.04 ± 0.005 |
0.13 ± 0.009 |
Number (%) abnormal cells with: |
|||||
Chromosome deletions |
1 (0.40) |
0 |
0 |
0 |
9 (3.6) |
Chromosome exchanges |
1 (0.4) |
0 |
0 |
0 |
2 (0.8) |
Chromatid deletions |
7 (2.9) |
11 (4.4) |
10 (4) |
4 (1.7) |
76 (30.4) |
Chromatid exchanges |
3 (1.3) |
7 (2.8) |
15 (6) |
7 (3) |
64 (25.6) |
Aneuploidy |
3 (1.3) |
3 (1) |
0 |
5 (2.2) |
10 (4) |
Polyploidy |
2 (0.8) |
3 (1) |
1 (0.40) |
0 |
0 |
Severe damage |
0 |
0 |
0 |
0 |
25 (10) |
Types of aberrations per cell: |
|||||
Overall frequency of aberrations (mean ± SEM) |
0.07 ± 0.02 |
0.11 ± 0.03 |
0.12 ± 0.03 |
0.09 ± 0.02 |
2.36 ± 0.70* |
Chromosome deletions |
0.004 |
0 |
0 |
0 |
0.05 |
Chromosome exchanges |
0.004 |
0 |
0 |
0 |
0.01 |
Chromatid deletions |
0.03 |
0.06 |
0.06 |
0.02 |
0.95 |
Chromatid exchanges |
0.01 |
0.03 |
0.06 |
0.04 |
0.45 |
Within the range finder, no mortality was observed at any dose tested. Mitotic indices ranged from 1.50 to 6.18 percent and showed no compound related effects. A dose of 5 g/kg was considered the MTD. For the definitive cytogenetic study, at the 24 hour sacrifice no mortality was observed at any dose tested. No compound related effects were observed at the doses tested. The positive control showed an approximately ten fold increase in aberrations compared to the untreated controls. At the 48 hour sacrifice no mortality was observed at any dose tested. No compound related effects were observed. The positive control showed approximately thirty fold increase in aberrations compared to the untreated controls.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
No mutagenic effects were observed at 24 or 48 hours post dosing, in the bone marrow cells of male rats dosed orally with 1.25, 2.5, or 5.00 g/kg sodium cyanurate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
